![]() | Clinical UM Guideline |
| Subject: | Gender Reassignment Surgery | ||
| Guideline #: | CG-SURG-27 | Current Effective Date: | 07/13/2011 |
| Status: | Reviewed | Last Review Date: | 05/19/2011 |
| Description |
Gender reassignment surgery is one treatment option for extreme cases of Gender Identity Disorder (GID), a condition in which a person feels a strong and persistent identification with the opposite gender accompanied with a severe sense of discomfort in their own gender. People with GID often report a feeling of being born the wrong sex. Gender reassignment surgery is not a single procedure, but part of a complex process involving multiple medical, psychiatric, and surgical specialists working in conjunction with each other and the individual to achieve successful behavioral and medical outcomes. Before undertaking gender reassignment surgery, important medical and psychological evaluations, medical therapies and behavioral trials should be undertaken to confirm that surgery is the most appropriate treatment choice for the individual.
Please refer to the following documents for additional information:
| Clinical Indications |
Medically Necessary:
Gender reassignment surgery* is considered medically necessary when all of the following criteria are met:
* Gender reassignment surgery may include any of the following procedures:
Male-to-Female Procedures
Female-to-Male Procedures
** At least one of the professionals submitting a letter must have a doctoral degree (Ph.D., M.D., Ed.D., D.Sc., D.S.W., or Psy.D) and be capable of adequately evaluating co-morbid psychiatric conditions. One letter is sufficient if signed by two providers, one of whom has met the doctoral degree specifications, in addition to the specifications set forth above.
Not Medically Necessary:
Gender reassignment surgery is considered not medically necessary when one or more of the criteria above have not been met.
Cosmetic:
The following surgeries are considered cosmetic when used to improve the gender specific appearance of an individual who has undergone or is planning to undergo gender reassignment surgery:
| Coding |
The following codes for treatments and procedures applicable to this document are included below for informational purposes. Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement policy. Please refer to the member's contract benefits in effect at the time of service to determine coverage or non-coverage of these services as it applies to an individual member.
| CPT | |
| 55970 | Intersex surgery; male to female |
| 55980 | Intersex surgery; female to male |
| Also combinations of individual procedures billed separately, including but not limited to | |
| 19325 | Mammaplasty, augmentation; with prosthetic implant |
| 54125 | Amputation of penis; complete |
| 54520 | Orchiectomy, simple (including subcapsular), with or without testicular prosthesis, scrotal or inguinal approach |
| 54660 | Insertion of testicular prosthesis |
| 54690 | Laparoscopy, surgical; orchiectomy |
| 55180 | Scrotoplasty; complicated |
| 56625 | Vulvectomy, simple; complete |
| 56800 | Plastic repair of introitus |
| 56805 | Clitoroplasty for intersex state |
| 57110 | Vaginectomy, complete removal of vaginal wall; |
| 57291 | Construction of artificial vagina; without graft |
| 57292 | Construction of artificial vagina; with graft |
| 57295 | Revision (including removal) of prosthetic vaginal graft; vaginal approach |
| 57296 | Revision (including removal) of prosthetic vaginal graft; open abdominal approach |
| 57426 | Revision (including removal) of prosthetic vaginal graft, laparoscopic approach |
| 58150 | Total abdominal hysterectomy (corpus and cervix), with or without removal of tube(s), with or without removal of ovary(s); |
| 58552 | Laparoscopy, surgical, with vaginal hysterectomy, for uterus 250 grams or less; with removal of tube(s) and/or ovary(s) |
| 58554 | Laparoscopy, surgical, with vaginal hysterectomy, for uterus greater than 250 grams; with removal of tube(s) and/or ovary(s) |
| 58571 | Laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(s) |
| 58573 | Laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s) |
| ICD-9 Procedure | |
| 62.41 | Removal of both testes at same operative episode |
| 62.7 | Insertion of testicular prosthesis |
| 64.3 | Amputation of penis |
| 64.43 | Construction of penis |
| 64.5 | Operations for sex transformation, not elsewhere classified |
| 65.61 | Other removal of both ovaries and tubes at same operative session |
| 65.63 | Laparoscopic removal of both ovaries and tubes at the same operative episode |
| 68.4 | Total abdominal hysterectomy |
| 68.51 | Laparoscopically assisted vaginal hysterectomy (LAVH) |
| 68.59 | Other vaginal hysterectomy |
| 70.4 | Obliteration and total excision of vagina |
| 70.61 | Vaginal construction |
| 71.4 | Operations on clitoris |
| 71.62 | Bilateral vulvectomy |
| ICD-9 Diagnosis | |
| 302.50-302.53 | Trans-sexualism |
| 302.6 | Gender identity disorder in children or NOS |
| 302.85 | Gender identity disorder in adolescents or adults |
Future ICD-10 coding (effective 10/01/2013)
A draft of ICD-10 Coding related to this document, as it might look today, is available for reference and comments at: Appendix 1: Future ICD-10 coding
| Discussion/General Information |
Gender Identity Disorder, commonly referred to as transsexualism, is a condition wherein an individual's psychological gender is the opposite of his or her anatomic sex. This results in the persistent feeling of being "trapped in the wrong body". This diagnosis should not be confused with cross dressing (transvestitism), refusal to accept homosexual orientation, psychotic delusions or personality disorders.
Surgical treatment differs depending upon the original physical gender of the individual. For male-to-female individuals, also known as "transwomen," surgery involves removal of the testicles and penis and the creation of pseudo vagina, clitoris, and labia. For female-to-male individuals, known as "transmen," surgery involves removal of the uterus, ovaries, and vagina, and creation of a neophallus, and scrotum with scrotal prostheses. At this time, the creation of a neophallus for transmen is a multistage reconstructive procedure.
The criteria in the SOC are supported by evidence-based peer-reviewed journal publications. Several studies have shown that extensive long-term trials of hormonal therapy and real-life experience living as the other gender, as well as social support and acceptance by peer and family groups, greatly improve psychological outcomes in individuals undergoing Gender reassignment surgery (Eldh, 1997; Landen, 1998). A study reported by Monstrey and colleagues (2001) described the importance of close cooperation between the many medical and behavioral specialties required for proper treatment of individuals with GID who wish to undergo gender reassignment surgery. Similar findings were reported earlier by Schlatterer et al. in 1996. One study of 188 subjects undergoing gender reassignment surgery found that dissatisfaction with surgery was highly associated with sexual preference, psychological co-morbidity, and poor pre-operative body image and satisfaction (Smith, 2005).
Gender reassignment surgery presents significant medical and psychological risks, and results are irreversible. A step-wise approach to therapy for GID, including accurate diagnosis and long-term treatment by a multidisciplinary team including behavioral, medical and surgical specialists, has been shown to provide the best results. As with any treatment involving psychiatric disorders, a thorough behavioral analysis by a qualified practitioner is needed. Once a diagnosis of GID is established, treatment with hormone therapy and establishment of real-life transgender experience may be warranted. Gender reassignment surgery should be considered only after such trials have been undertaken, evaluated and confirmed. Hormone therapy should be administered under ongoing medical supervision and is important in beginning the gender transition process by altering body hair, breast size, skin appearance and texture, body fat distribution, and the size and function of sex organs. Additionally, real-life experience is important to validate the individual's desire and ability to incorporate into their desired gender role within their social network and daily environment. This generally involves gender-specific appearance (garments, hairstyle, etc.), involvement in various activities in the desired gender role including work or academic settings, legal acquisition of a gender appropriate first name, and acknowledgement by others of their new gender role.
Once these treatment steps have been established and stable for at least 12 months, an individual may be considered for gender reassignment surgery.
For both transmen and transwomen, additional surgeries have been proposed to improve the gender appropriate appearance of the individual. Procedures such as breast augmentation, liposuction, Adam's apple reduction, rhinoplasty, facial reconstruction, and others have no medically necessary role in gender identification and are considered cosmetic in nature.
| References |
Peer Reviewed Publications:
Government Agency, Medical Society, and Other Authoritative Publications:
| Index |
Sex Change
Sex Reassignment
| History |
Status | Date | Action |
| Reviewed | 05/19/2011 | Medical Policy & Technology Assessment Committee (MPTAC) review. No change to position statement. |
| Reviewed | 05/13/2010 | MPTAC review. No change to position statement. Updated Reference section. |
| Reviewed | 11/19/2009 | MPTAC review. No change to indications. Updated Coding section with 01/01/2010 CPT changes. |
| Reviewed | 11/20/2008 | MPTAC review. No change to indications. Updated coding section |
| Reviewed | 11/29/2007 | MPTAC review. No change to policy position statement. Updated Coding section with 01/01/2008 CPT changes. |
| New | 12/07/2006 | Medical Policy & Technology Assessment Committee (MPTAC) initial guideline development. |